Answer
Axitinib (Inlyta) is contraindicated in patients with hypersensitivity to axitinib or any of the excipients listed in section 6.1 of its product information.
Sources for this answer
- Inlyta 5 mg film-coated tabletsPfizer Limited · emc · SmPC §4.3 Contraindications · Version 17Document updated
Sources checked